Jus A, Jus K, Fontaine P
J Clin Psychiatry. 1979 Feb;40(2):72-7.
A 4 year trial to treat tardive dyskinesia by a very slow progressive stepwise diminution of the neuroleptic dose and of antiparkinsonian agents as well as by administration of small, slowly increasing and then decreasing doses of reserpine or haloperidol was conducted on 62 chronic schizophrenic patients. This treatment program caused disappearance of tardive dyskinesia in 23, improvement in 26 patients and had no effect in 13 patients. The group of patients with disappearance of tardive dyskinesia had a mean age significantly lower than other groups. The rationale of this treatment was based on the concept of "desensitization" by a slow, progressive unblocking of dopaminergic receptor sites. Another tardive neuroleptic side effect, the "rabbit syndrome" was successfully treated in 7 other patients by antiparkinsonian drugs.
对62例慢性精神分裂症患者进行了一项为期4年的试验,通过非常缓慢地逐步减少抗精神病药物剂量和抗帕金森病药物剂量,以及给予小剂量、缓慢增加然后减少的利血平或氟哌啶醇来治疗迟发性运动障碍。该治疗方案使23例患者的迟发性运动障碍消失,26例患者病情改善,13例患者无效。迟发性运动障碍消失的患者组平均年龄显著低于其他组。这种治疗的基本原理基于通过缓慢、逐步解除多巴胺能受体位点的“脱敏”概念。另外7例患者的另一种迟发性抗精神病药物副作用“兔综合征”通过抗帕金森病药物成功治愈。